 | Up a level |
Papamargaritis, Dimitris, Al-Najim, Werd, Lim, Jonathan 
ORCID: 0000-0003-3682-8910, Crane, James, Lean, Mike, Le Roux, Carel, McGowan, Barbara, O'Shea, Donal, Webb, David, Wilding, John ORCID: 0000-0003-2839-8404 et al (show 1 more authors)
(2020)
Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial.
BMJ OPEN, 10 (2).
e034137-.
O'Neil, Patrick M, Birkenfeld, Andreas L, McGowan, Barbara, Mosenzon, Ofri, Pedersen, Sue D, Wharton, Sean, Carson, Charlotte Giwercman, Jepsen, Cecilie Heerdegen, Kabisch, Maria and Wilding, John PH ORCID: 0000-0003-2839-8404
(2018)
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
LANCET, 392 (10148).
pp. 637-649.